Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hassel

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
Der Radiologe|January 23, 2015
[Melanoma: introduction and special demands on radiology]M Schiller, J C Hassel
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Side effects of dermato-oncologic therapies]Jessica C Hassel, Lisa Zimmer
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 17, 2009
Chemotherapeutics, chemoresistance and the management of melanomaK Rass, J C Hassel
Dermatologie (Heidelberg, Germany)|June 4, 2024
[Side effects of oncologic therapies]Lisa Zimmer, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2024
Jessica C Hassel, Carola Berking
Future Oncology (London, England)|February 17, 2022
Tebentafusp for the treatment of metastatic uveal melanomaTimo E Schank, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 6, 2025
Cutaneous sarcoid-like-reaction in herpes zoster scar tissue of a melanoma patient on adjuvant targeted therapyAnastasia S Vollmer, Jessica C Hassel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Autoantibodies as Predictors for Clinical Outcome and Toxicity for ImmunotherapyJessica C Hassel, Jason J Luke
Cancers|July 27, 2019
Immunotherapies for the Treatment of Uveal Melanoma-History and FutureTimo E Schank, Jessica C Hassel
Frontiers in Immunology|July 14, 2018
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondKristina Buder-Bakhaya, Jessica C Hassel
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
Der Radiologe|January 23, 2015
[Melanoma: introduction and special demands on radiology]M Schiller, J C Hassel
Dermatologie (Heidelberg, Germany)|May 27, 2024
[Side effects of dermato-oncologic therapies]Jessica C Hassel, Lisa Zimmer
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|February 17, 2009
Chemotherapeutics, chemoresistance and the management of melanomaK Rass, J C Hassel
Dermatologie (Heidelberg, Germany)|June 4, 2024
[Side effects of oncologic therapies]Lisa Zimmer, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 7, 2024
Jessica C Hassel, Carola Berking
Future Oncology (London, England)|February 17, 2022
Tebentafusp for the treatment of metastatic uveal melanomaTimo E Schank, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 6, 2025
Cutaneous sarcoid-like-reaction in herpes zoster scar tissue of a melanoma patient on adjuvant targeted therapyAnastasia S Vollmer, Jessica C Hassel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2022
Autoantibodies as Predictors for Clinical Outcome and Toxicity for ImmunotherapyJessica C Hassel, Jason J Luke
Cancers|July 27, 2019
Immunotherapies for the Treatment of Uveal Melanoma-History and FutureTimo E Schank, Jessica C Hassel
Frontiers in Immunology|July 14, 2018
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and BeyondKristina Buder-Bakhaya, Jessica C Hassel
Pageof 33